ART GROUP HOLD (00565) subsidiary intends to sell the entire equity interest in Xuansheng International
ART GROUP HOLD (00565) announced that on October 5, 2026, the seller (Right Lane International Limited, a direct wholly-owned subsidiary of the Company) intends to sell to the buyer Chen Wenlan the entire issued share capital of the target company (Xuansheng International Limited) for a consideration of HK$1.
ART GROUP HOLD (00565) announced that on October 5, 2026, the seller (Right Lane International Limited, a direct wholly-owned subsidiary of the company) intends to sell the entire issued share capital of the sold company (Xuansheng International Limited) to the buyer Chen Wenlan for a consideration of HK$1.
The sold company is an investment holding company. The sold group has been principally engaged in property operations in China. The disposal enables the group to optimize its assets and resource allocation and focus on areas and businesses with stronger growth potential. This move also allows the group to redeploy internal resources to support its other existing principal businesses by eliminating loss-making operations, thereby enhancing the group's overall financial flexibility.
Related Articles

CUTIA-B (02487) repurchased 40,800 shares for HK$39,700 on October 5.

AI compute demand outlook viewed favorably; BNP Paribas raises target prices for NVIDIA Corporation (NVDA.US) and Intel Corporation (INTC.US), but remains cautious on the latter.

SINOPHARM TECH (08156) restores public float
CUTIA-B (02487) repurchased 40,800 shares for HK$39,700 on October 5.

AI compute demand outlook viewed favorably; BNP Paribas raises target prices for NVIDIA Corporation (NVDA.US) and Intel Corporation (INTC.US), but remains cautious on the latter.

SINOPHARM TECH (08156) restores public float






